Epidemiology of fracture risk in the Women's Health Initiative

被引：19

作者：

Jackson R.D. ^{[1
]}

Donepudi S. ^{[1
]}

Mysiw W.J. ^{[1
]}

机构：

[1] Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH 43210

来源：

Current Osteoporosis Reports | 2008年 / 6卷 / 4期

关键词：

Bone Mineral Density; Fracture Risk; Clinical Risk Factor; Minority Woman; Bioavailable Testosterone;

D O I：

10.1007/s11914-008-0027-3

中图分类号：

学科分类号：

摘要：

Osteoporosis is one of the most disabling consequences of aging in women. Strategies that permit earlier identification of women at risk for fracture are needed. The Women's Health Initiative has extended our knowledge of clinical risk factors and biomarkers of fracture risk in postmenopausal women. Based upon 11 clinically available risk factors (age, race/ethnicity, self-reported health, weight, height, physical activity, parental hip fracture, fracture history after age 54, current smoking, corticosteroid use, and history of treated diabetes), an algorithm has been developed to predict 5-year hip fracture risk. Biomarkers including low vitamin D or bioavailable testosterone and/or high cystatin C or sex hormone-binding globulin also predict risk for hip fracture independent of clinical risk factors. To address the growing incidence of fractures in minority women, clinical risk factors for fracture have been identified. These data demonstrate that we can better identify women, irrespective of race or ethnicity, at risk for fracture. © Springer Science+Business Media, LLC 2008.

引用

页码：155 / 161

页数：6

共 30 条

[11]

Hui S.L., Slemenda C.W., Johnston C.C., Age and bone mass as predictors of fracture in a prospective study, J Clin Invest, 81, pp. 1804-1809, (1988)

[12]

Design of the Women's Health Initiative clinical trial and observational study, Control Clin Trials, 339, pp. 733-738, (1998)

[13]

LaFleur J., McAdam-Marx C., Kirkness C., Brixner D.I., Clinical risk factors for fracture in postmenopausal osteoporotic women: A review of the recent literature, Ann Pharmacother, 42, pp. 375-386, (2008)

[14]

Robbins J., Aragaki A.K., Kooperberg C., Et al., Factors associated with 5-year risk of hip fracture in postmenopausal women, JAMA, 298, pp. 2389-2398, (2007)

[15]

Black D.M., Steinbuch M., Palermo L., Et al., An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos Int, 12, pp. 519-528, (2001)

[16]

Dargent-Molina P., Douchin M.N., Cormier C., Et al., Use of clinical risk factors in elderly women with low bone mineral density to identify women at high risk for hip fracture: The EPIDOS prospective study, Osteoporos Int, 13, pp. 593-599, (2002)

[17]

Miller P.D., Barles S., Brenneman S.K., Et al., An approach for identifying osteopenic women at increased short-term risk of fracture, Arch Intern Med, 164, pp. 1113-1120, (2004)

[18]

McGrother C.W., Donaldson M.M., Clayton D., Et al., Evaluation of a hip fracture risk score for assessing elderly women: The Melton Osteoporotic Fracture (MOF) study, Osteoporos Int, 13, pp. 89-96, (2002)

[19]

Kanis J.A., Oden A., Johnell O., Et al., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women, Osteoporos Int, 18, pp. 133-1046, (2007)

[20]

Kanis J.A., Johnell O., Johansson H., McCloskey E., FRAX and the assessment of fracture probability in men and women from the UK, Osteoporos Int, 19, pp. 385-397, (2008)

← 1 2 3 →